David Greenwald, MD
Urology · Santa Cruz
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Dominican Hospital · Sutter Maternity & Surgery Center of Santa Cruz. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Greenwald’s office at (831) 477-2350 to ask if they take your plan before you enroll.
California Medical Board record
Licence A172235 · Current
Licensed to practise in California · since 2021 · expires 2027-04-30 · West Virginia University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
- Sutter Maternity & Surgery Center of Santa CruzSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 85% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Maternity & Surgery Center of Santa Cruz
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.12) · 59 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.01 (0.5 to 1.52) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 63 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 118 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 116 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.95) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.28 (0.56 to 4) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.41 (0 to 18.05) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.75 (2.52 to 10.98) · 102 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0 to 1.94) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 30 cases | None | Apr 2023 – Mar 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.7 (9.2 to 14.9) · 3,197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 506 cases | No different | Jan 2024 – Dec 2024 |
What patients said (203 patients answered, 24% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 93% |
| Yes, staff "did" give patients information about help after discharge | 96% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 87% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 69% |
| "YES", patients would definitely recommend the hospital | 85% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$180,155
Medicare paid this office $180,155 for 589 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 215 | $28,959 | $95 |
| Short return visit (20+ min) | 287 | $23,324 | $67 |
| New patient visit (45+ min) | 168 | $20,505 | $122 |
| Diagnostic exam of bladder and urethra using an endoscope | 62 | $15,371 | $213 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 17 | $14,073 | None |
See all 14 services
| Return visit (30+ min) | 215 | $28,959 | $95 |
| Short return visit (20+ min) | 287 | $23,324 | $67 |
| New patient visit (45+ min) | 168 | $20,505 | $122 |
| Diagnostic exam of bladder and urethra using an endoscope | 62 | $15,371 | $213 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 17 | $14,073 | None |
| Simple bladder irrigation and/or instillation | 23 | $5,685 | $66 |
| Limited ultrasound scan of pelvis | 100 | $4,756 | $40 |
| Simple change of bladder tube | 18 | $4,236 | $83 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 223 | $3,600 | $13 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,647 | $106 |
| Manual urinalysis test with examination using microscope, automated | 296 | $1,574 | $3 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $1,289 | $21 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 19 | $1,196 | $32 |
| Injection of drug or substance under skin or into muscle | 15 | $415 | $13 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Who their Medicare patients are
589 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 13% · Women 30% · Also on Medicaid 18% · Health risk score 1.28. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 65% · Cancer 27% · Coronary heart disease 23% · Diabetes 22% · Atrial fibrillation 22% · Chronic kidney disease 21% · Depression 16% · Heart failure 14% · COPD 8% · Dementia 5% · Stroke 3%.
The office billed $968,073, Medicare allowed $243,610 and paid $180,155; for 13,050 services of 81 kinds; $34,198 of it was for drugs given in the office and $145,957 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 589 | 13,050 | 75 | 1.28 | $968,073 | $180,155 |
| 2023 | 649 | 18,318 | 76 | 1.22 | $1,177,601 | $215,877 |
| 2022 | 583 | 8,133 | 75 | 1.20 | $959,671 | $192,355 |
| 2021 | 284 | 3,945 | 75 | 1.12 | $291,845 | $65,659 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Short return visit (20+ min) | 309 | $27,802 | $67 |
| Return visit (30+ min) | 192 | $27,057 | $107 |
| Diagnostic exam of bladder and urethra using an endoscope | 86 | $21,631 | $221 |
| New patient visit (45+ min) | 163 | $19,913 | $122 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 15 | $12,483 | None |
| Insertion of lower leg neurostimulator electrode | 42 | $11,234 | $109 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 19 | $7,887 | $358 |
| Limited ultrasound scan of pelvis | 109 | $5,526 | $42 |
| Simple change of bladder tube | 27 | $4,192 | $82 |
| Simple bladder irrigation and/or instillation | 21 | $3,741 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,702 | $104 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 63 | $2,181 | $21 |
| Manual urinalysis test with examination using microscope, automated | 316 | $1,695 | $3 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,257 | $70 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $1,022 | $79 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $861 | $32 |
| Simple insertion of temporary bladder tube | 11 | $627 | $48 |
| Injection of drug or substance under skin or into muscle | 15 | $461 | $13 |
2022: 18 services
| Return visit (30+ min) | 321 | $45,805 | $101 |
| New patient visit (45+ min) | 184 | $22,616 | $123 |
| Diagnostic exam of bladder and urethra using an endoscope | 80 | $20,489 | $230 |
| Short return visit (20+ min) | 120 | $10,016 | $75 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 12 | $7,341 | None |
| Crushing of stone of ureter with insertion of stent using an endoscope | 19 | $6,744 | $355 |
| Long return visit (40+ min) | 40 | $6,530 | $152 |
| Limited ultrasound scan of pelvis | 80 | $4,029 | $42 |
| Insertion of lower leg neurostimulator electrode | 23 | $3,863 | $99 |
| Simple bladder irrigation and/or instillation | 23 | $3,681 | $68 |
| Needle biopsy of prostate gland using image guidance | 11 | $3,560 | $324 |
| New patient visit (60+ min) | 16 | $3,089 | $193 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $3,072 | $114 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 64 | $2,052 | $20 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $2,005 | $84 |
| Manual urinalysis test with examination using microscope, automated | 238 | $1,065 | $3 |
| Simple insertion of temporary bladder tube | 15 | $1,038 | $55 |
| Injection of drug or substance under skin or into muscle | 15 | $297 | $13 |
2021: 9 services
| Return visit (30+ min) | 104 | $13,046 | $112 |
| New patient visit (45+ min) | 61 | $8,464 | $139 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | $6,155 | $212 |
| Short return visit (20+ min) | 73 | $6,024 | $78 |
| Insertion of lower leg neurostimulator electrode | 27 | $4,601 | $118 |
| Simple bladder irrigation and/or instillation | 16 | $2,035 | $73 |
| Long return visit (40+ min) | 12 | $1,905 | $159 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 48 | $1,343 | $21 |
| Manual urinalysis test with examination using microscope, automated | 87 | $333 | $3 |
Medicaid work
$4,228 in 2023
Medicaid paid $4,228 for 171 billed services this clinician did in 2023, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 29 | $2,109 |
| Short return visit (20+ min) | 45 | $2,021 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 97 | $98 |
| 2023 | 171 | 3 | 19 | $4,228 |
| 2022 | 143 | 2 | 19 | $13,518 |
| 2021 | 36 | 2 | 12 | $2,849 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 99 | $7,632 |
| New patient visit (45+ min) | 44 | $5,886 |
2021
| Return visit (30+ min) | 24 | $1,554 |
| New patient visit (45+ min) | 12 | $1,295 |
Drugs they prescribed that Part D paid
$166,143
Pharmacies billed $166,143 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,038 generic and 193 brand-name prescriptions · $166,143 in drug cost · 182 antibiotic prescriptions to 93 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 86 | $60,820 | $707 |
| Gemtesa | 81 | $55,033 | $679 |
| Elmiron | 13 | $11,450 | $881 |
| Methenamine Hippurate | 83 | $6,106 | $74 |
| Tamsulosin | 275 | $4,373 | $16 |
See all 18 drugs
| Myrbetriq | 86 | $60,820 | $707 |
| Gemtesa | 81 | $55,033 | $679 |
| Elmiron | 13 | $11,450 | $881 |
| Methenamine Hippurate | 83 | $6,106 | $74 |
| Tamsulosin | 275 | $4,373 | $16 |
| Finasteride | 226 | $3,392 | $15 |
| Tadalafil | 27 | $3,369 | $125 |
| Estradiol | 44 | $2,846 | $65 |
| Potassium Citrate Er | 24 | $2,766 | $115 |
| Tolterodine Tartrate Er | 13 | $950 | $73 |
| Dutasteride | 19 | $739 | $39 |
| Oxybutynin Chloride Er | 16 | $731 | $46 |
| Nitrofurantoin Mono-Macro | 35 | $553 | $16 |
| Trospium Chloride | 15 | $328 | $22 |
| Alfuzosin Hcl Er | 20 | $320 | $16 |
| Cephalexin | 42 | $265 | $6 |
| Sulfamethoxazole-Trimethoprim | 36 | $114 | $3 |
| Ciprofloxacin | 14 | $37 | $3 |
Year by year
| 2024 | 1,231 | 351 | None | 16% | $166,143 |
| 2023 | 1,150 | 315 | None | None | $193,983 |
| 2022 | 840 | 259 | None | 22% | $125,565 |
| 2021 | 118 | 83 | None | 18% | $12,370 |
| 2020 | 21 | None | None | 0% | $219 |
| 2019 | 58 | 33 | 22% (13) | None | $2,350 |
| 2018 | 44 | 27 | 27% (12) | None | $11,564 |
| 2017 | 34 | 20 | None | None | $8,546 |
| 2016 | 42 | 14 | None | None | $4,175 |
| 2015 | 169 | 66 | 15% (26) | 17% | $19,863 |
| 2014 | 48 | 20 | None | 25% | $10,353 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Myrbetriq | 132 | $93,352 | $707 |
| Gemtesa | 58 | $46,264 | $798 |
| Elmiron | 14 | $14,706 | $1,050 |
| Tamsulosin | 258 | $6,154 | $24 |
| Potassium Citrate Er | 33 | $4,420 | $134 |
| Methenamine Hippurate | 63 | $4,375 | $69 |
| Finasteride | 193 | $3,793 | $20 |
| Estradiol | 26 | $3,071 | $118 |
| Dutasteride | 25 | $1,628 | $65 |
| Oxybutynin Chloride Er | 18 | $1,325 | $74 |
| Nitrofurantoin Mono-Macro | 32 | $996 | $31 |
| Tadalafil | 20 | $720 | $36 |
| Cephalexin | 51 | $323 | $6 |
| Sulfamethoxazole-Trimethoprim | 49 | $271 | $6 |
| Ciprofloxacin | 16 | $114 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $109 | $8 |
2022: 14 drugs
| Myrbetriq | 134 | $80,142 | $598 |
| Potassium Citrate Er | 22 | $2,906 | $132 |
| Dutasteride | 27 | $2,893 | $107 |
| Tamsulosin | 164 | $2,851 | $17 |
| Tolterodine Tartrate Er | 12 | $2,811 | $234 |
| Finasteride | 161 | $2,770 | $17 |
| Methenamine Hippurate | 34 | $2,644 | $78 |
| Estradiol | 11 | $1,314 | $119 |
| Oxybutynin Chloride Er | 25 | $927 | $37 |
| Nitrofurantoin Mono-Macro | 20 | $741 | $37 |
| Tadalafil | 14 | $653 | $47 |
| Cephalexin | 30 | $203 | $7 |
| Sulfamethoxazole-Trimethoprim | 39 | $198 | $5 |
| Ciprofloxacin | 15 | $64 | $4 |
2021: 4 drugs
| Myrbetriq | 18 | $8,300 | $461 |
| Tamsulosin | 24 | $365 | $15 |
| Finasteride | 14 | $309 | $22 |
| Ciprofloxacin | 11 | $67 | $6 |
2020: 1 drug
| Finasteride | 12 | $76 | $6 |
2019: 1 drug
| Finasteride | 15 | $122 | $8 |
2016: 1 drug
| Tamsulosin | 11 | $311 | $28 |
2015: 5 drugs
| Myrbetriq | 18 | $5,274 | $293 |
| Tamsulosin | 15 | $462 | $31 |
| Gabapentin | 16 | $208 | $13 |
| Hydrocodone-Acetaminophen | 22 | $179 | $8 |
| Amlodipine Besylate | 11 | $35 | $3 |
Money from drug and device companies
$271 in 2025
| 2025 | 2 | 2 | None | $271 |
| 2024 | 1 | 1 | None | $54 |
| 2021 | 1 | 1 | None | $92 |
| 2019 | 4 | 6 | None | $201 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Calyxo | Cvac Aspiration System | $138 | 1 payment
|
| Procept Biorobotics | Aquabeam Robotic System | $133 | 1 payment
|
See all 2 published payments
| Calyxo | Meals · 2025-04-26 | Cvac Aspiration System | $138 |
| Procept Biorobotics | Meals · 2025-04-26 | Aquabeam Robotic System | $133 |
See earlier years (2024, 2021, 2019)
2024: $54
| SRS Medical Systems | Ct3000 Pro Base Unit | $54 | 1 payment
|
2021: $92
| Boston Scientific | Lithovue | $92 | 1 payment
|
2019: $201
| Boston Scientific | General Erectile Dysfunction | $122 | 2 payments
|
| Blue Earth Diagnostics | Axumin | $37 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $31 | 1 payment
|
| Medtronic USA | Interstim | $11 | 1 payment
|
Professional record
- NPI
- 1134563372
- Licence
- CA A172235California A172235: Current · expires 2027-04-30
- Trained
- West Virginia University School of Medicine, 2013
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 2911 Chanticleer Ave, Santa Cruz, CA, 95065
- NPI first listed
- 2013-04-18
- NPI last updated
- 2021-09-21
- NPI record certified
- 2021-04-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Palo Alto, CA, 94304